Setting

North America Pain Management Devices Market 2021-2031 by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain, Others), Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248559 | Pages: 93

North America Pain Management Devices Market is projected to grow by 7.6% annually in the forecast period and reach $4,435.4 million by 2031, driven by the growing demand for chronic pain management among the geriatric population, the increasing availability of technically advanced pain management devices, supportive reimbursement policies and adverse effects of pain medications, and the growing awareness of pain management devices. Highlighted with 23 tables and 43 figures, this 93-page report “North America Pain Management Devices Market 2021-2031 by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, Ablation Devices), Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain, Others), Mode of Purchase (Prescription, OTC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America Pain Management Devices Market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Five Forces

 

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America pain management devices market in every aspect of the classification from perspectives of Product, Application, Mode of Purchase, and Country.

 

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Neuromodulation & Neurostimulation Devices

   o Spinal Cord Stimulators

   o Transcutaneous Electrical Nerve Stimulation (TENS) Devices

   o Sacral Nerve Stimulators

   o Deep Brain Stimulators

   o Other Neuromodulation & Neurostimulation Devices

• Analgesic Infusion Pumps

   o External Infusion Pumps

   o Intrathecal Infusion Pumps

• Ablation Devices

   o Radiofrequency Ablation Devices

   o Cryoablation Devices

 

Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Neuropathic Pain

• Musculoskeletal Pain

• Cancer Pain

• Facial & Migraine Pain

• Other Applications

 

By Mode of Purchase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Prescription

• Over-the-counter (OTC)

 

Geographically, the following national/local markets are fully investigated:

• U.S.

• Canada

• Mexico

 

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and Mode of Purchase over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players:

Abbott Laboratories

B. Braun Melsungen AG

Baxter International Inc.

Becton, Dickinson and Company

Boston Scientific Corp.

Colfax Corporation (DJO Global LLC)

Johnson & Johnson (Codman and Shurtleff, Inc.)

Kimberly Clark Corporation

Medtronic Plc.

Nevro Corp

Pfizer, Inc.

Smiths Medical, Inc.

Stryker Corp.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of North America Market by Product 39
3.1 Market Overview by Product 39
3.2 Neuromodulation & Neurostimulation Devices 41
3.2.1 Spinal Cord Stimulators 43
3.2.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices 44
3.2.3 Sacral Nerve Stimulators 45
3.2.4 Deep Brain Stimulators 46
3.2.5 Other Neuromodulation & Neurostimulation Devices 47
3.3 Analgesic Infusion Pumps 48
3.3.1 External Infusion Pumps 49
3.3.2 Intrathecal Infusion Pumps 50
3.4 Ablation Devices 51
3.4.1 Radiofrequency Ablation Devices 52
3.4.2 Cryoablation Devices 53
4 Segmentation of North America Market by Application 54
4.1 Market Overview by Application 54
4.2 Neuropathic Pain 56
4.3 Musculoskeletal Pain 57
4.4 Cancer Pain 58
4.5 Facial & Migraine Pain 59
4.6 Other Applications 60
5 Segmentation of North America Market by Mode of Purchase 61
5.1 Market Overview by Mode of Purchase 61
5.2 Prescription 63
5.3 Over-the-counter (OTC) 64
6 North America Market 2021-2031 by Country 65
6.1 Overview of North America Market 65
6.2 U.S. 68
6.3 Canada 71
6.4 Mexico 73
7 Competitive Landscape 75
7.1 Overview of Key Vendors 75
7.2 New Product Launch, Partnership, Investment, and M&A 78
7.3 Company Profiles 79
Abbott Laboratories 79
B. Braun Melsungen AG 81
Baxter International Inc. 82
Becton, Dickinson and Company 83
Boston Scientific Corp. 84
Colfax Corporation (DJO Global LLC) 85
Johnson & Johnson (Codman and Shurtleff, Inc.) 86
Kimberly Clark Corporation 87
Medtronic Plc. 88
Nevro Corp 89
Pfizer, Inc. 90
Smiths Medical, Inc. 91
Stryker Corp. 92
RELATED REPORTS 93


List of Tables:

Table 1. Snapshot of North America Pain Management Devices Market in Balanced Perspective, 2021-2031 16
Table 2. World Economic Outlook, 2021-2031 19
Table 3. World Health Spending by Region, $ bn, 2013-2020 27
Table 4. Main Product Trends and Market Opportunities in North America Pain Management Devices Market 31
Table 5. North America Pain Management Devices Market by Product, 2021-2031, $ mn 39
Table 6. North America Pain Management Devices Market: Neuromodulation & Neurostimulation Devices by Type, 2021-2031, $ mn 42
Table 7. North America Pain Management Devices Market: Analgesic Infusion Pumps by Type, 2021-2031, $ mn 48
Table 8. North America Pain Management Devices Market: Ablation Devices by Type, 2021-2031, $ mn 51
Table 9. North America Pain Management Devices Market by Application, 2021-2031, $ mn 54
Table 10. North America Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 61
Table 11. North America Pain Management Devices Market by Country, 2021-2031, $ mn 66
Table 12. U.S. Pain Management Devices Market by Product, 2021-2031, $ mn 70
Table 13. U.S. Pain Management Devices Market by Application, 2021-2031, $ mn 70
Table 14. U.S. Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 70
Table 15. Canada Pain Management Devices Market by Product, 2021-2031, $ mn 72
Table 16. Canada Pain Management Devices Market by Application, 2021-2031, $ mn 72
Table 17. Canada Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 72
Table 18. Mexico Pain Management Devices Market by Product, 2021-2031, $ mn 74
Table 19. Mexico Pain Management Devices Market by Application, 2021-2031, $ mn 74
Table 20. Mexico Pain Management Devices Market by Mode of Purchase, 2021-2031, $ mn 74
Table 21. Abbott Laboratories: Company Snapshot 79
Table 22. Abbott Laboratories: Business Segmentation 80
Table 23. Abbott Laboratories: Product Portfolio 80

List of Figures:

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. North America Pain Management Devices Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of North America Pain Management Devices Market 22
Figure 7. Leading Causes of Death in the World, 2019-2020, million 25
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 26
Figure 10. Primary Restraints and Impact Factors of North America Pain Management Devices Market 28
Figure 11. Investment Opportunity Analysis 32
Figure 12. Porter’s Fiver Forces Analysis of North America Pain Management Devices Market 35
Figure 13. Breakdown of North America Pain Management Devices Market by Product, 2021-2031, % of Revenue 40
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 40
Figure 15. North America Pain Management Devices Market by Product: Neuromodulation & Neurostimulation Devices, 2021-2031, $ mn 41
Figure 16. North America Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Spinal Cord Stimulators, 2021-2031, $ mn 43
Figure 17. North America Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, 2021-2031, $ mn 44
Figure 18. North America Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Sacral Nerve Stimulators, 2021-2031, $ mn 45
Figure 19. North America Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Deep Brain Stimulators, 2021-2031, $ mn 46
Figure 20. North America Pain Management Devices Market by Neuromodulation & Neurostimulation Devices: Other Neuromodulation & Neurostimulation Devices, 2021-2031, $ mn 47
Figure 21. North America Pain Management Devices Market by Product: Analgesic Infusion Pumps, 2021-2031, $ mn 48
Figure 22. North America Pain Management Devices Market by Analgesic Infusion Pumps: External Infusion Pumps, 2021-2031, $ mn 49
Figure 23. North America Pain Management Devices Market by Analgesic Infusion Pumps: Intrathecal Infusion Pumps, 2021-2031, $ mn 50
Figure 24. North America Pain Management Devices Market by Product: Ablation Devices, 2021-2031, $ mn 51
Figure 25. North America Pain Management Devices Market by Ablation Devices: Radiofrequency Ablation Devices, 2021-2031, $ mn 52
Figure 26. North America Pain Management Devices Market by Ablation Devices: Cryoablation Devices, 2021-2031, $ mn 53
Figure 27. Breakdown of North America Pain Management Devices Market by Application, 2021-2031, % of Sales Revenue 55
Figure 28. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 55
Figure 29. North America Pain Management Devices Market by Application: Neuropathic Pain, 2021-2031, $ mn 56
Figure 30. North America Pain Management Devices Market by Application: Musculoskeletal Pain, 2021-2031, $ mn 57
Figure 31. North America Pain Management Devices Market by Application: Cancer Pain, 2021-2031, $ mn 58
Figure 32. North America Pain Management Devices Market by Application: Facial & Migraine Pain, 2021-2031, $ mn 59
Figure 33. North America Pain Management Devices Market by Application: Other Applications, 2021-2031, $ mn 60
Figure 34. Breakdown of North America Pain Management Devices Market by Mode of Purchase, 2021-2031, % of Sales Revenue 62
Figure 35. North America Addressable Market Cap in 2022-2031 by Mode of Purchase, Value ($ mn) and Share (%) 62
Figure 36. North America Pain Management Devices Market by Mode of Purchase: Prescription, 2021-2031, $ mn 63
Figure 37. North America Pain Management Devices Market by Mode of Purchase: Over-the-counter (OTC), 2021-2031, $ mn 64
Figure 38. Breakdown of North America Pain Management Devices Market by Country, 2021 and 2031, % of Revenue 66
Figure 39. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 67
Figure 40. U.S. Pain Management Devices Market, 2021-2031, $ mn 69
Figure 41. Canada Pain Management Devices Market, 2021-2031, $ mn 71
Figure 42. Pain Management Devices Market in Mexico, 2021-2031, $ mn 73
Figure 43. Growth Stage of North America Pain Management Devices Industry over the Forecast Period 75
Selected Key Players: 
Abbott Laboratories
B. Braun Melsungen AG
Baxter International Inc.
Becton, Dickinson and Company
Boston Scientific Corp.
Colfax Corporation (DJO Global LLC)
Johnson & Johnson (Codman and Shurtleff, Inc.)
Kimberly Clark Corporation
Medtronic Plc.
Nevro Corp
Pfizer, Inc.
Smiths Medical, Inc.
Stryker Corp. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)